These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 36436139

  • 1. Establishment and characterization of NCC-PLPS2-C1: a novel cell line of pleomorphic liposarcoma.
    Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Osaki J, Adachi Y, Ono T, Tsuchiya R, Sato C, Iwata S, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2023 Jan; 36(1):468-475. PubMed ID: 36436139
    [Abstract] [Full Text] [Related]

  • 2. Establishment and characterization of NCC-PLPS1-C1, a novel patient-derived cell line of pleomorphic liposarcoma.
    Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T.
    Hum Cell; 2021 Mar; 34(2):688-697. PubMed ID: 33205363
    [Abstract] [Full Text] [Related]

  • 3. Establishment and characterization of NCC-PS1-C1: a novel cell line of pleomorphic sarcoma from a patient after neoadjuvant radiotherapy.
    Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Sugaya J, Kobayashi E, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2022 Nov; 35(6):2011-2019. PubMed ID: 36103079
    [Abstract] [Full Text] [Related]

  • 4. Establishment and characterization of NCC-DDLPS1-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
    Tsuchiya R, Yoshimatsu Y, Noguchi R, Sei A, Takeshita F, Sugaya J, Fukushima S, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2021 Jan; 34(1):260-270. PubMed ID: 32949334
    [Abstract] [Full Text] [Related]

  • 5. Establishment and characterization of a novel cell line, NCC-DDLPS2-C1, derived from a patient with dedifferentiated liposarcoma.
    Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T.
    Hum Cell; 2021 May; 34(3):990-997. PubMed ID: 33555519
    [Abstract] [Full Text] [Related]

  • 6. Establishment and characterization of NCC-DDLPS3-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
    Tsuchiya R, Yoshimatsu Y, Noguchi R, Ono T, Sei A, Takeshita F, Sugaya J, Fukushima S, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2021 May; 34(3):1008-1018. PubMed ID: 33677797
    [Abstract] [Full Text] [Related]

  • 7. Establishment and characterization of NCC-DDLPS5-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
    Sin Y, Yoshimatsu Y, Noguchi R, Tsuchiya R, Ono T, Akiyama T, Iwata S, Sugaya J, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2022 May; 35(3):936-943. PubMed ID: 35292923
    [Abstract] [Full Text] [Related]

  • 8. Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li-Fraumeni syndrome.
    Ono T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Akiyama T, Sugaya J, Fukushima S, Kojima N, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2022 Mar; 35(2):756-766. PubMed ID: 35118583
    [Abstract] [Full Text] [Related]

  • 9. Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Kiyuna T, Tome Y, Murakami T, Kawaguchi K, Igarashi K, Miyake K, Miyake M, Li Y, Nelson SD, Dry SM, Singh AS, Russell TA, Elliott I, Singh SR, Kanaya F, Eilber FC, Hoffman RM.
    BMC Cancer; 2018 Aug 20; 18(1):840. PubMed ID: 30126369
    [Abstract] [Full Text] [Related]

  • 10. Establishment and characterization of a novel patient-derived cell line of dedifferentiated liposarcoma, NCC-DDLPS6-C1.
    Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Akiyama T, Nakagawa R, Kamio S, Hirabayashi K, Ozawa I, Kikuta K, Kondo T.
    Hum Cell; 2022 Jul 20; 35(4):1270-1278. PubMed ID: 35604485
    [Abstract] [Full Text] [Related]

  • 11. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
    Mariño-Enríquez A, Hornick JL, Dal Cin P, Cibas ES, Qian X.
    Cancer Cytopathol; 2014 Feb 20; 122(2):128-37. PubMed ID: 24227706
    [Abstract] [Full Text] [Related]

  • 12. Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor.
    Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Sato C, Kojima N, Yoshida A, Kawai A, Ohtori S, Kondo T.
    Hum Cell; 2022 Nov 20; 35(6):2002-2010. PubMed ID: 35927606
    [Abstract] [Full Text] [Related]

  • 13. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
    Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Sei A, Takeshita F, Sugaya J, Nakatani F, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2021 Sep 20; 34(5):1569-1578. PubMed ID: 34164773
    [Abstract] [Full Text] [Related]

  • 14. Establishment and characterization of NCC-MLPS1-C1: a novel patient-derived cell line of myxoid liposarcoma.
    Noguchi R, Yoshimatsu Y, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T.
    Hum Cell; 2021 Mar 20; 34(2):667-674. PubMed ID: 33146842
    [Abstract] [Full Text] [Related]

  • 15. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
    Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Akiyama T, Sugaya J, Nakatani F, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2022 Jan 20; 35(1):384-391. PubMed ID: 34665443
    [Abstract] [Full Text] [Related]

  • 16. Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma.
    Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Fukushima S, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2020 Oct 20; 33(4):1302-1310. PubMed ID: 32648033
    [Abstract] [Full Text] [Related]

  • 17. Establishment and characterization of two novel patient-derived myxoid liposarcoma cell lines.
    Noguchi R, Yoshimatsu Y, Sin Y, Tsuchiya R, Ono T, Akiyama T, Hirabayashi K, Ozawa I, Nakagawa R, Kikuta K, Kondo T.
    Hum Cell; 2022 Jul 20; 35(4):1279-1289. PubMed ID: 35637403
    [Abstract] [Full Text] [Related]

  • 18. Establishment and characterization of NCC-DSM1-C1: a novel cell line derived from a patient with desmoid fibromatosis.
    Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Osaki J, Ono T, Adachi Y, Tsuchiya R, Toda Y, Kobayashi E, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2023 Mar 20; 36(2):847-853. PubMed ID: 36629983
    [Abstract] [Full Text] [Related]

  • 19. Establishment and characterization of NCC-LMS2-C1-a novel patient-derived cancer cell line of leiomyosarcoma.
    Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T.
    Hum Cell; 2021 Jan 20; 34(1):279-288. PubMed ID: 33001379
    [Abstract] [Full Text] [Related]

  • 20. Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study.
    Dermawan JK, Hwang S, Wexler L, Tap WD, Singer S, Vanderbilt CM, Antonescu CR.
    Mod Pathol; 2022 Nov 20; 35(11):1644-1655. PubMed ID: 35672466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.